Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Salmonella enterica serovar Typhi and Paratyphi

Fluoroquinolone non-susceptibility and multi-drug resistance

Salmonella enterica bacteria © CDC

GRAM estimates the global prevalence of Salmonella enterica serovar Typhi and Paratyphi infections with observed fluoroquinolone non-susceptibility and multi-drug resistance over time. Based on a detailed systematic review and statistical analysis, findings are due for release in 2023.